Forecasters predict pharma’s multi-billion-dollar TV ad buys will shrink in 2023

A pharma retrenching may be one contributor to what ad forecasting firms say will be slower advertising growth than previously expected.

by Marc Iskowitz

To continue reading this article you need to be registered with Campaign. Registration is free and only takes a minute. Register here or sign in below if you already have an account.

Sign in

Register

  • Limited free articles a month
  • Free email bulletins

Register Now

Become a member

From $169 a year

  • Full access to campaignlive.com
  • Exclusive event discounts
  • Plus lots more...

Choose a package

Need to activate  your membership?